AbbVie's (NYSE:ABBV) autoimmune disease biologic Humira (adalimumab) and Pfizer (NYSE:PFE)/BioNTech's (BNTX) COVID-19 shot ...

The autumn wave of coronavirus is sweeping across Germany. Those affected mainly suffer from coughs, colds, sore throats and ...

Pfizer remains an attractive capital return play with a 10X P/E ratio, despite concerns about post-COVID revenue declines.

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

A federal judge has dismissed a lawsuit by a New York family who claimed the Department of Defense misled Americans into ...

Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...

A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

These five top stocks trade at reasonable levels and offer the strength that makes sense as we enter a very volatile time of ...

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...

Pfizer PFE stock has risen 7.3% in the past three months compared with an increase of 2.9% for the industry. The stock has ...